Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant (Q30761595)

26 June 2017

title

Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant (English)

1 reference

Herpes simplex virus type 1

26 June 2017

main subject

1 reference

Kokoris MS

1 reference

26 June 2017

Sabo P

series ordinal

1 reference

26 June 2017

Adman ET

series ordinal

1 reference

26 June 2017

Black ME

series ordinal

1 reference

26 June 2017

publication date

1 August 1999

1 reference

26 June 2017

1 reference

26 June 2017

1 reference

26 June 2017

1 reference

26 June 2017

page(s)

1415-1426

1 reference

Regression of established macroscopic liver metastases after in situ transduction of a suicide gene

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

An experimental model of retrovirus gene therapy for malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Effect on substrate binding of an alteration at the conserved aspartic acid-162 in herpes simplex virus type 1 thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Crystal structures of the thymidine kinase from herpes simplex virus type-1 in complex with deoxythymidine and ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Differentiated rat glial cell strain in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Glial culture on artificial capillaries: electron microscopic comparisons of C6 rat glioma cells and rat astroglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Characteristics of C6 glioma cells overexpressing a gap junction protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Intracellular Pools of Thymidine Reduce the Antiviral Action of Acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Herpesviral deoxythymidine kinases contain a site analogous to the phosphoryl-binding arginine-rich region of porcine adenylate kinase; comparison of secondary structure predictions and conservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Gene therapy for vascular smooth muscle cell proliferation after arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Expression of a Tat-inducible herpes simplex virus-thymidine kinase gene protects acyclovir-treated CD4 cells from HIV-1 spread by conditional suicide and inhibition of reverse transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Cell-free synthesis of enzymatically active vaccinia virus thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Improved methods for building protein models in electron density maps and the location of errors in these models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

inferred from DOI database lookup

7 January 2021

based on heuristic

Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300966

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3300966

1 reference

26 June 2017

1 reference